| Date Filed | Type | Description |
| 03/14/2023 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 10,697 shares
@ $44.81, valued at
$479.3k
Sold 15,649 shares
@ $45.31, valued at
$709.1k
Sold 1,566 shares
@ $46.13, valued at
$72.2k
Exercised 27,912 options to buy
@ $14, valued at
$390.8k
|
|
| 12/19/2022 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 14,500 options to buy
@ $27.58, valued at
$399.9k
|
|
| 12/16/2022 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 7,800 shares
@ $43.59, valued at
$340k
Sold 8,597 shares
@ $44.54, valued at
$382.9k
Sold 13,603 shares
@ $45.49, valued at
$618.8k
Exercised 16,149 options to buy
@ $14.18, valued at
$229k
Exercised 13,851 options to buy
@ $14, valued at
$193.9k
|
|
| 12/05/2022 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 5,659 shares
@ $44.33, valued at
$250.9k
|
|
| 11/28/2022 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 63,000 shares
@ $0
Granted 134,000 options to buy
@ $45, valued at
$6M
|
|
| 02/15/2022 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 1,627 shares
@ $0
Granted 6,401 shares
@ $0
Paid exercise price by delivering 2,355 shares
@ $62.49, valued at
$147.2k
|
|
| 01/18/2022 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 10,063 options to buy
@ $11.77, valued at
$118.4k
|
|
| 12/17/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 25,700 shares
@ $0
Granted 107,800 options to buy
@ $75.33, valued at
$8.1M
|
|
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,201 shares
@ $42.52, valued at
$93.6k
Exercised 7,500 restricted stock units
@ $0 |
|
| 11/20/2020 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 26,500 shares
@ $0
Granted 107,800 options to buy
@ $43.57, valued at
$4.7M
|
|
| 03/04/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,330 shares
@ $63.88, valued at
$212.7k
Exercised 7,500 restricted stock units
@ $0 |
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
SC 13D
| Luly Jay R. reports a 5% stake in Enanta Pharmaceuticals, Inc. |
| 11/20/2018 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 68,000 options to buy
@ $81.2, valued at
$5.5M
|
|
| 07/30/2018 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 8,498 options to buy
@ $11.7663, valued at
$100k
|
|
| 07/09/2018 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 2,977 shares
@ $123.8051, valued at
$368.6k
Sold 12,622 shares
@ $124.264, valued at
$1.6M
Sold 7,538 shares
@ $125.2673, valued at
$944.3k
Sold 7,738 shares
@ $126.3618, valued at
$977.8k
Sold 4,125 shares
@ $127.1222, valued at
$524.4k
|
|
| 05/18/2018 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 14,032 shares
@ $105.8233, valued at
$1.5M
Sold 10,968 shares
@ $105.8299, valued at
$1.2M
|
|
| 02/13/2018 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 8,600 shares
@ $0
Granted 20,737 shares
@ $0
Paid exercise price by delivering 11,132 shares
@ $76.845, valued at
$855.4k
|
|
| 11/21/2017 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $48.52, valued at
$4.9M
|
|
| 04/14/2017 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 13,925 options to buy
@ $14, valued at
$195k
|
|
| 02/15/2017 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 6,800 shares
@ $0
Paid exercise price by delivering 2,278 shares
@ $29.815, valued at
$67.9k
|
|
| 11/22/2016 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 120,000 options to buy
@ $30, valued at
$3.6M
Granted 15,000 restricted stock units
@ $0 |
|
| 09/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |